Showing results (141-150 of 396) with videos related to
Sort By:
Pageof 40
Seminars in Diagnostic Pathology|August 1, 1984
New cytomorphologic methods in the diagnosis of bone tumors: possibilities and limitationsA Roessner, W Mellin, W Hiddemann, et al.Pathology, Research and Practice|December 1, 1985
Biological characterization of human bone tumors. VII. Detection of malignancy in a giant cell tumor of bone by flow cytometric DNA-analysisW Mellin, A Roessner, E Grundmann, et al.Leukemia|April 1, 1997
Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blastsC Reuter, E Schleyer, C Rolf, et al.European Journal of Clinical Pharmacology|October 16, 2001
Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patientsB Erdlenbruch, M Nier, W Kern, et al.Cancer|January 1, 1997
High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias. Results of a clinical phase II studyW Kern, E Schleyer, M Unterhalt, et al.Blood|February 1, 1982
Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemiaW Hiddemann, B D Clarkson, T Büchner, et al.Blut|June 20, 1978
[Clinical and cell kinetic data on the combination of cytosine arabinoside with daunorubicin, isosfamide, thioguanine, and vincristine for remission induction and maintenance in patients with acute myelocytic leukaemia (author's transl)]T h Büchner, D Kamanabroo, D Urbanitz, et al.Acta Haematologica|August 7, 1999
Hypercoagulability in a patient with hypodysfibrinogenemia: implications for clinical managementG G Wulf, M Unterhalt, A Buchwald, et al.Anticancer Research|March 28, 2001
Microalbuminuria during cisplatin therapy: relation with pharmacokinetics and implications for nephroprotectionW Kern, J Braess, C C Kaufmann, et al.Best Practice & Research. Clinical Haematology|May 18, 2001
Acute myeloid leukaemia (AML): treatment of the older patientT Büchner, W Hiddemann, C Schoch, et al.Pageof 40